ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 16 analysts with 12-month price forecasts for ACADIA Pharmaceuticals stock have an average target of 24, with a low estimate of 19 and a high estimate of 31. The average target predicts an increase of 43.88% from the current stock price of 16.68.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$19	$24	$23	$31
Change	+13.91%	+43.88%	+37.89%	+85.85%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	6	6	6	6	5	4
Buy	6	6	6	6	6	5
Hold	7	7	7	7	8	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	19	19	19	19	19	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold Initiates $20	Hold	Initiates	$20	+19.90%	Mar 7, 2025
Charles Duncan Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $28	Buy	Reiterates	$28	+67.87%	Feb 27, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $27	Strong Buy	Reiterates	$27	+61.87%	Feb 27, 2025
Ami Fadia Needham	Needham	Strong Buy Reiterates $28	Strong Buy	Reiterates	$28	+67.87%	Feb 27, 2025
Neena Bitritto-Garg Deutsche Bank	Deutsche Bank	Hold Initiates $22	Hold	Initiates	$22	+31.89%	Feb 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.08B

Increased by 13.07%

from 957.80M

Revenue Next Year

1.19B

Increased by 9.97%

from 1.08B

EPS This Year

0.66

Decreased by -51.38%

from 1.36

EPS Next Year

0.97

Increased by 47.46%

from 0.66

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	441.76M	484.15M	517.24M	726.44M	957.80M	1.08B	1.19B	1.32B
Revenue Growth	30.28%	9.60%	6.83%	40.45%	31.85%	13.07%	9.97%	10.58%
EPS	-1.79	-1.05	-1.34	-0.37	1.36	0.66	0.97	1.47
EPS Growth	-	-	-	-	-	-51.38%	47.46%	51.08%
Forward PE	-	-	-	-	-	25.23	17.11	11.32
No. Analysts	-	-	-	-	-	22	19	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1.1B	1.4B	1.6B
Avg	1.1B	1.2B	1.3B
Low	983.1M	1.1B	1.2B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	19.3%	30.7%	36.1%
Avg	13.1%	10.0%	10.6%
Low	2.6%	-1.4%	-3.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	1.40	1.97	2.50
Avg	0.66	0.97	1.47
Low	0.08	0.33	0.89

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	2.7%	198.5%	156.3%
Avg	-51.4%	47.5%	51.1%
Low	-94.2%	-49.6%	-8.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.